Prof Charles Swanton at ESMO 2014: The TRACERx study of NSCLC

Prof Charles Swanton at ESMO 2014: The TRACERx study of NSCLC

User Photo
EMJ

5 years
989 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Charles Swanton (London Research Institute and University College London, UK) discusses TRAcking Cancer Evolution through therapy (TRACERx), which is a study that defines lung cancer in both space and time through multiregion and longitudinal tumour sampling and genetic analysis.
Up Next Autoplay